Clinical Marrow Transplantation

[1]  E. Thomas,et al.  Marrow transplantation for malignant disease. , 1987, The American journal of the medical sciences.

[2]  D. Brahams.  Human immunodeficiency virus and the law. , 1987, Lancet.

[3]  S. Feig,et al.  Marrow transplantation for thalassemia. , 1986, Bone marrow transplantation.

[4]  A. Rimm,et al.  Increasing utilization of bone marrow transplantation. , 1986, Transplantation.

[5]  R. Gale.  Potential utilization of a national HLA-typed donor pool for bone marrow transplantation. , 1986, Transplantation.

[6]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.

[7]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. , 1986, Annals of internal medicine.

[8]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[9]  H. Deeg,et al.  Marrow transplantation for the treatment of chronic myelogenous leukemia. , 1986, Annals of internal medicine.

[10]  R. Marcus,et al.  Bone marrow transplantation for patients with chronic myeloid leukemia. , 1986, The New England journal of medicine.

[11]  R. Storb,et al.  Marrow transplantation from related donors other than HLA-identical siblings. , 1985, The New England journal of medicine.

[12]  H. Deeg,et al.  Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts , 1985 .

[13]  Kennedy,et al.  Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. , 1985, Blood.

[14]  R. Elashoff,et al.  Treatment of Acute Myelogenous Leukemia: A Prospective Controlled Trial of Bone Marrow Transplantation Versus Consolidation Chemotherapy , 1985 .

[15]  H. Deeg,et al.  Marrow transplantation for leukemia following fractionated total body irradiation. A comparative trial of methotrexate and cyclosporine. , 1985, Leukemia research.

[16]  J. Crowley,et al.  Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. A prospective comparison. , 1984, Annals of internal medicine.

[17]  G. Hale,et al.  ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1) , 1984, The Lancet.

[18]  H. Deeg,et al.  Marrow transplantation for aplastic anemia. , 1974, Seminars in hematology.

[19]  R. Storb,et al.  Immunologic reconstitution after human marrow grafting. , 1984, Seminars in hematology.

[20]  E. Thomas.  Karnofsky Memorial Lecture. Marrow transplantation for malignant diseases. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  F. Appelbaum,et al.  Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  B. Dupont,et al.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. , 1983, Blood.

[23]  E. Gordon-Smith,et al.  Bone-marrow transplantation for severe aplastic anaemia using histocompatible unrelated volunteer donors. , 1982, British medical journal.

[24]  K. Sullivan,et al.  MARROW TRANSPLANTATION FOR THALASSAEMIA , 1982, The Lancet.

[25]  A. Rimm,et al.  Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. , 1981, JAMA.

[26]  J. Hansen,et al.  Marrow transplantation from donors other than HLA identical siblings. , 1981, Human immunology.

[27]  J. Woodruff,et al.  The Graft-vs.-Host Reaction in Man , 1981 .

[28]  R. Storb,et al.  Transplantation of marrow from an unrelated donor to a patient with acute leukemia. , 1980, The New England journal of medicine.

[29]  H. Cann,et al.  Linkage disequilibria between HLA-B and the rarer properdin factor B alleles, BfF1 and BfS1. , 1980, Human immunology.

[30]  P. Neiman,et al.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission. , 1979, The New England journal of medicine.

[31]  P. Neiman,et al.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. , 1977, Blood.

[32]  Rawlings Sw,et al.  Household and family characteristics , 1977 .

[33]  A. Rimm,et al.  Severe combined immunodeficiency disease: characterization of the disease and results of transplantation. , 1977, Transplantation proceedings.

[34]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.

[35]  F. Bach,et al.  Bone Marrow and Thymus Transplants: Cellular Engineering to Correct Primary Immunodeficiency , 1974 .

[36]  W. Elkins.  Cellular immunology and the pathogenesis of graft versus host reactions. , 1971, Progress in allergy.

[37]  Williams Ja.  SKIN LESIONS AS RESERVOIRS OF HOSPITAL INFECTION. , 1965 .

[38]  J. Cannon,et al.  Supralethal whole body irradiation and isologous marrow transplantation in man. , 1959, The Journal of clinical investigation.

[39]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .